View in EDS HTML Full Text PDF Full Text

Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.

Saved in:
Bibliographic Details
Title: Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study.
Authors: Venegas-Rodríguez, Rafael1 (AUTHOR), Serrano-Díaz, Anabel2 (AUTHOR), Peña-Ruiz, Ruben1 (AUTHOR), Santana-Sánchez, Raul1 (AUTHOR), Hernández-Cedeño, Mabel2 (AUTHOR), Rittoles Navarro, Aliusha1 (AUTHOR), Grecesqui-Cruz, Inti1 (AUTHOR), Pérez-Aguilera, Liam1 (AUTHOR), Segura-Fernández, Anadys1 (AUTHOR), Rosario-Cruz, Leticia1 (AUTHOR), Martínez-Donato, Gilliam2 (AUTHOR), Guillén-Nieto, Gerardo2 (AUTHOR), Domínguez- Horta, Maria del Carmen2 (AUTHOR) mcarmen.dominguez@cigb.edu.cu
Source: PLoS ONE. 2/2/2023, Vol. 18 Issue 2, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0281111